IP Library Assignment 063124/0305
Patent Assignment
Reel/Frame 063124/0305

Assignment of Assignor's Interest

Recorded: 2023-03-21 Pages: 26
Assignor
HORIZON PHARMA RHEUMATOLOGY LLC
Executed: 2020-03-31
Assignee
HORIZON THERAPEUTICS USA, INC.
1 HORIZON WAY, DEERFIELD, ILLINOIS, 60015
Covered Property (1)
Methods and Kits for Predicting Infusion Reaction Risk and Antibody-Mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy
Application: 18/104,578 →
Publication: US 2023/0251247
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 21, 2023
From: ROSARIO-JANSEN, THERESA; WRIGHT, DAVID ERICK
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 063050/0097 →
Change of Name Mar 21, 2023
From: CREALTA PHARMACEUTICALS LLC
To: HORIZON PHARMA USA RHEUMATOLOGY LLC
Reel/Frame 063123/0273 →
Assignment of Assignor's Interest Mar 21, 2023
From: SAVIENT PHARMACEUTICALS, INC.; SAVIENT PHARMA HOLDINGS, INC.
To: CREALTA PHARMACEUTICALS LLC
Reel/Frame 063124/0342 →
Change of Name Mar 21, 2023
From: HORIZON PHARMA USA RHEUMATOLOGY LLC
To: HORIZON PHARMA RHEUMATOLOGY LLC
Reel/Frame 064464/0900 →